ENT320: 20k in 20 Days - Agile Genomic Analysis - a podcast by AWS

AstraZeneca is a global science-led biopharmaceutical company developing innovative medicines used by millions of patients worldwide. With AWS, AstraZeneca processed more exomes in 20 days than during the previous 3 years, enabling scientists to receive results more quickly, develop medicines faster, and treat more patients sooner. AstraZeneca was able to identify ~20% more patients with actionable variants of major cancer types by using VarDict, an internally developed, open source contributed variant caller, at scale in the Cloud. Learn how AstraZeneca used the AWS Cloud Services to rapidly develop and scale an asynchronous architecture to meet an urgent business opportunity, accelerating the speed of scientific discovery in a cost effective manner.

Further episodes of AWS re:Invent 2016

Further podcasts by AWS

Website of AWS